| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.08 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.08 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.08 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |